This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 592319
Submitted by lobbyist on: October 13, 2016 04:30:31 PM
Accepted by Registrar on: October 14, 2016 10:01:33 AM
Designated Filer Information
| Keon, James J |
| 4120 Yonge Street Suite 409 | |
|
Toronto, ON, M2P 2B8
|
416-223-2333 |
| Canada |
Organization Information
| Canadian Generic Pharmaceutical Association (CGPA) |
| The CGPA's mission is to promote an environment which supports and enhances the provision of affordable generic medications to Canadians and patients around the world. The Association researches and develops positions regarding a wide variety of policies, regulations and legislation that affects our member companies. We promote our sector's interests by publishing material as well as directly contacting government officials, the media and other opinion leaders and decision makers. |
| 4120 Yonge Street Suite 409 | |
|
Toronto, ON, M2P 2B8
|
416-223-2333 |
| Canada |
Relevant Affiliates
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
| October 13, 2016 | |
| April 11, 2017 |
Organization's In-House Lobbyists
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
Introduction, modification or repeal of legislation, a bill or regulation
Alignment of British Columbia's listing and pricing policies for generic drugs with that of the pan-Canadian National Pharmaceutical Alliance. Addressing delays in listing certain generic drugs due to requirement of a Ministerial Order and discussion of alternatives. Addressing impact of expansion and modification of Reference Drug Program on generic manufacturers. Addressing potential amendments to Drug Price Regulation regarding annual listing process for generic drugs. Protecting the interests of Canada's generic pharmaceutical industry should the Trans-Pacific partnership be ratified and during implementation of the Comprehensive Economic and Trade Agreement.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| MLA | Darcy, Judy | New Westminster | March 29, 2017 |
| Public Agency | Health | October 13, 2016 | |
| Public Agency | Office of the Premier | October 13, 2016 |
International Trade
Development, establishment, amendment or termination of any program, policy or decision
Protecting the interests of Canada's generic pharmaceutical industry should the Trans-Pacific partnership be ratified and during implementation of the Comprehensive Economic and Trade Agreement.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | October 13, 2016 | |
| Public Agency | International Trade | October 13, 2016 | |
| Public Agency | Office of the Premier | October 13, 2016 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
International Trade
Development, establishment, amendment or termination of any program, policy or decision
Protecting the interests of Canada's generic pharmaceutical industry should the Trans-Pacific partnership be ratified and during implementation of the Comprehensive Economic and Trade Agreement.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | International Trade | October 13, 2016 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
Introduction, modification or repeal of legislation, a bill or regulation
Alignment of British Columbia's listing and pricing policies for generic drugs with that of the pan-Canadian National Pharmaceutical Alliance. Addressing delays in listing certain generic drugs due to requirement of a Ministerial Order and discussion of alternatives. Addressing impact of expansion and modification of Reference Drug Program on generic manufacturers. Addressing potential amendments to Drug Price Regulation regarding annual listing process for generic drugs. Protecting the interests of Canada's generic pharmaceutical industry should the Trans-Pacific partnership be ratified and during implementation of the Comprehensive Economic and Trade Agreement.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| MLA | Darcy, Judy | New Westminster | March 29, 2017 |
| Public Agency | Health | October 13, 2016 | |
| Public Agency | Office of the Premier | October 13, 2016 |
International Trade
Development, establishment, amendment or termination of any program, policy or decision
Protecting the interests of Canada's generic pharmaceutical industry should the Trans-Pacific partnership be ratified and during implementation of the Comprehensive Economic and Trade Agreement.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | October 13, 2016 | |
| Public Agency | International Trade | October 13, 2016 | |
| Public Agency | Office of the Premier | October 13, 2016 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
Introduction, modification or repeal of legislation, a bill or regulation
Alignment of British Columbia's listing and pricing policies for generic drugs with that of the pan-Canadian National Pharmaceutical Alliance. Addressing delays in listing certain generic drugs due to requirement of a Ministerial Order and discussion of alternatives. Addressing impact of expansion and modification of Reference Drug Program on generic manufacturers. Addressing potential amendments to Drug Price Regulation regarding annual listing process for generic drugs. Protecting the interests of Canada's generic pharmaceutical industry should the Trans-Pacific partnership be ratified and during implementation of the Comprehensive Economic and Trade Agreement.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | October 13, 2016 | |
| Public Agency | Office of the Premier | October 13, 2016 |
International Trade
Development, establishment, amendment or termination of any program, policy or decision
Protecting the interests of Canada's generic pharmaceutical industry should the Trans-Pacific partnership be ratified and during implementation of the Comprehensive Economic and Trade Agreement.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | October 13, 2016 | |
| Public Agency | International Trade | October 13, 2016 | |
| Public Agency | Office of the Premier | October 13, 2016 |